Risk factors associated with default from multi- and extensively drug-resistant tuberculosis treatment, uzbekistan: a retrospective cohort analysis.
AuthorsLalor, M K
du Cros, P
AffiliationMédecins Sans Frontières, Nukus, Karakalpakstan, Uzbekistan.
MetadataShow full item record
AbstractThe Médecins Sans Frontières project of Uzbekistan has provided multidrug-resistant tuberculosis treatment in the Karakalpakstan region since 2003. Rates of default from treatment have been high, despite psychosocial support, increasing particularly since programme scale-up in 2007. We aimed to determine factors associated with default in multi- and extensively drug-resistant tuberculosis patients who started treatment between 2003 and 2008 and thus had finished approximately 2 years of treatment by the end of 2010.
- Retrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes.
- Authors: Lee J, Lee CH, Kim DK, Yoon HI, Kim JY, Lee SM, Yang SC, Lee JH, Yoo CG, Lee CT, Chung HS, Kim YW, Han SK, Yim JJ
- Issue date: 2011 Jun
- Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study.
- Authors: Muture BN, Keraka MN, Kimuu PK, Kabiru EW, Ombeka VO, Oguya F
- Issue date: 2011 Sep 9
- Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
- Authors: Blöndal K, Viiklepp P, Guðmundsson LJ, Altraja A
- Issue date: 2012 Sep
- [Extensively drug resistant and extremely drug resistant tuberculosis forms after multi-drug resistant tuberculosis: new faces of the old disease].
- Authors: Baylan O
- Issue date: 2011 Jan
- Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
- Authors: Migliori GB, Lange C, Girardi E, Centis R, Besozzi G, Kliiman K, Ortmann J, Matteelli A, Spanevello A, Cirillo DM, SMIRA/TBNET Study Group.
- Issue date: 2008 Mar 15